Skip to main content
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.347
+0.023 (7.21%)
At close: Jul 2, 2024, 4:00 PM
0.348
+0.002 (0.43%)
After-hours: Jul 2, 2024, 7:57 PM EDT

Ginkgo Bioworks Holdings Revenue

Ginkgo Bioworks Holdings had revenue of $208.70M in the twelve months ending March 31, 2024, down -46.49% year-over-year. Revenue in the quarter ending March 31, 2024 was $37.94M, a -52.98% decrease year-over-year. In the year 2023, Ginkgo Bioworks Holdings had annual revenue of $251.46M, a decrease of -47.36%.

Revenue (ttm)
$208.70M
Revenue Growth
-46.49%
P/S Ratio
3.67
Revenue / Employee
$171,344
Employees
1,218
Market Cap
766.21M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareDx 275.11M
Aurinia Pharmaceuticals 191.41M
Harrow Health 138.68M
CureVac 64.13M
Mesoblast 7.25M
Dianthus Therapeutics 2.26M
Viridian Therapeutics 288.00K
Revenue Rankings

DNA News

More News